AN OPEN-LABEL STUDY OF FAMOTIDINE AS A TREATMENT FOR SCHIZOPHRENIA

被引：0
|
作者：
WHITEFORD, HA
STEDMAN, TJ
MCGRATH, JJ
WELHAM, J
POND, S
机构：
来源：
JOURNAL OF PSYCHIATRY & NEUROSCIENCE | 1995年 / 20卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：239 / 240
页数：2
相关论文
共 50 条
  • [41] An open-label study of citalopram in the treatment of pathological gambling
    Zimmerman, M
    Breen, RB
    Posternak, MA
    JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (01) : 44 - 48
  • [42] Treatment of viral warts with cimetidine: an open-label study
    Gooptu, C
    Higgins, CR
    James, MP
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2000, 25 (03) : 183 - 185
  • [43] THE OPTIMISE STUDY: AMISULPRIDE AND OLANZAPINE FOLLOWED BY OPEN-LABEL TREATMENT WITH CLOZAPINE IN FIRST-EPISODE SCHIZOPHRENIA
    Arango, Celso
    SCHIZOPHRENIA BULLETIN, 2019, 45 : S115 - S115
  • [44] Vardenafil in the treatment of erectile dysfunction in outpatients with chronic schizophrenia: A flexible-dose, open-label study
    Mitsonis, Charalampos I.
    Mitropoulos, Panagiotis A.
    Dimopoulos, Nikolaos P.
    Kararizou, Evangelia G.
    Psarra, Vasiliki V.
    Tsakiris, Fivos E.
    Katsanou, Maria-Nefeli E.
    JOURNAL OF CLINICAL PSYCHIATRY, 2008, 69 (02) : 206 - 212
  • [45] Olanzapine treatment in chronic drug-resistant childhood-onset schizophrenia: An open-label study
    Mozes, T
    Greenberg, Y
    Spivak, B
    Tyano, S
    Weizman, A
    Mester, R
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2003, 13 (03) : 311 - 317
  • [46] Yi-Gan San as Adjunctive Therapy for Treatment-Resistant Schizophrenia: An Open-Label Study
    Miyaoka, Tsuyoshi
    Furuya, Motohide
    Yasuda, Hideaki
    Hayashida, Maiko
    Nishida, Akira
    Inagaki, Takuji
    Horiguchi, Jun
    CLINICAL NEUROPHARMACOLOGY, 2009, 32 (01) : 6 - 9
  • [47] OPEN-LABEL STUDIES TO ASSESS PHARMACOKINETICS: SAVOLITINIB IN COMBINATION WITH MIDAZOLAM OR FAMOTIDINE.
    Ren, S.
    Vishwanathan, K.
    Cantarini, M.
    Frewer, P.
    Hara, I.
    Scarfe, G.
    Burke, W.
    Schalkwijk, S.
    Li, Y.
    Goldwater, R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S67 - S67
  • [48] Long-term treatment of chronic schizophrenia with risperidone: an open-label, multicenter study of 386 patients
    Moller, HJ
    Gagiano, CA
    Addington, DE
    Von Knorring, L
    Torres-Plank, JF
    Gaussares, C
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1998, 13 (03) : 99 - 106
  • [49] A prospective, multicentre, open-label study to evaluate the effectiveness of aripiprazole in the treatment of a broad range of patients with schizophrenia
    Peuskens, J.
    Bervoets, C.
    Kok, F.
    Delatte, B.
    Touquet, G.
    Gillain, B.
    de Patoul, A.
    Halkin, V.
    Loze, J. -Y.
    Vansteelandt, K.
    Constant, E.
    EUROPEAN PSYCHIATRY, 2012, 27 (07) : 506 - 512
  • [50] Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: An open-label switch study
    Lindenmayer, JP
    Czobor, P
    Volavka, J
    Lieberman, JA
    Citrome, L
    Sheitman, B
    Chakos, M
    McEvoy, JP
    JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (10) : 931 - 935
12345